{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:04:20Z","timestamp":1791468260488,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-SP-112-01"],"award-info":[{"award-number":["TCMF-SP-112-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-MP-114-02-01"],"award-info":[{"award-number":["TCMF-MP-114-02-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00192-026-06651-2","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:00:03Z","timestamp":1777989603000},"page":"2999-3007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Different Cystoscopic Bladder Conditions on the Therapeutic Outcomes of Intravesical Platelet-Rich Plasma Injections in Patients with Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"Wan-Ru","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"10","key":"6651_CR1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41585-025-01044-4","volume":"22","author":"JF Jhang","year":"2025","unstructured":"Jhang JF, Yu WR, Jiang YH, Kuo HC. Pathophysiology and potential multimodal therapeutic strategies for IC\/BPS. Nat Rev Urol. 2025;22(10):672\u201386.","journal-title":"Nat Rev Urol"},{"key":"6651_CR2","doi-asserted-by":"crossref","unstructured":"Buford K, Peters KM, Riedl C, Mishra NN, Jacques WJ, Lov\u00e1sz S, et al. Global consensus on interstitial cystitis\/bladder pain syndrome: an update on therapeutic treatments.\u00a0Neurourol Urodyn. 2026;45(1):46\u201353.","DOI":"10.1002\/nau.70106"},{"issue":"7","key":"6651_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s11255-025-04388-3","volume":"57","author":"YC Chiu","year":"2025","unstructured":"Chiu YC, Tsai PC, Jhang JF, Kuo HC. Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis\/bladder pain syndrome after different bladder therapies through urinary biomarker analysis. Int Urol Nephrol. 2025;57(7):2073\u201380.","journal-title":"Int Urol Nephrol"},{"key":"6651_CR4","doi-asserted-by":"crossref","unstructured":"Sandberg ML, Santurri L, Klumpp D, Rodriguez LV, Clauw D, Lai H. A review of the etiopathology of phenotypes in interstitial cystitis\/bladder pain syndrome.\u00a0Neurourol Urodyn. 2026;45(1):11\u20138.","DOI":"10.1002\/nau.70097"},{"issue":"4","key":"6651_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1464-410X.2012.11466.x","volume":"111","author":"JH Shie","year":"2013","unstructured":"Shie JH, Liu HT, Wang YS, Kuo HC. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis\/bladder pain syndrome. BJU Int. 2013;111(4):638\u201346.","journal-title":"BJU Int"},{"issue":"1","key":"6651_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000546901","volume":"17","author":"A Janev","year":"2025","unstructured":"Janev A, Zupan\u010di\u010d D, Verani\u010d P, Kuret T. Oxidative stress and chronic inflammation as partners in crime in interstitial cystitis\/bladder pain syndrome. J Innate Immun. 2025;17(1):369\u201396.","journal-title":"J Innate Immun"},{"issue":"6","key":"6651_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00192-024-05793-5","volume":"35","author":"S Knox","year":"2024","unstructured":"Knox S, Offiah I, Hashim H. Evaluation of central sensitisation in bladder pain syndrome: a systematic review. Int Urogynecol J. 2024;35(6):1109\u201318.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"6651_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092051","volume":"12","author":"WR Yu","year":"2024","unstructured":"Yu WR, Jhang JF, Jiang YH, Kuo HC. The pathomechanism and current treatments for chronic interstitial cystitis and bladder pain syndrome. Biomedicines. 2024;12(9):2051.","journal-title":"Biomedicines"},{"issue":"1","key":"6651_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.juro.2016.06.089","volume":"197","author":"S Regauer","year":"2017","unstructured":"Regauer S, Gamper M, Fehr MK, Viereck V. Sensory hyperinnervation distinguishes bladder pain syndrome\/interstitial cystitis from overactive bladder syndrome. J Urol. 2017;197(1):159\u201366.","journal-title":"J Urol"},{"issue":"1","key":"6651_CR10","doi-asserted-by":"publisher","first-page":"225.e13","DOI":"10.1016\/j.urology.2012.01.047","volume":"80","author":"HT Liu","year":"2012","unstructured":"Liu HT, Shie JH, Chen SH, Wang YS, Kuo HC. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis\/bladder pain syndrome. Urology. 2012;80(1):225.e13-8.","journal-title":"Urology"},{"issue":"6","key":"6651_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/JU.0000000000002974","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens JQ, Erickson DR, Lai HH. Diagnosis and treatment of\u00a0interstitial\u00a0cystitis\/bladder pain syndrome. Reply. J Urol. 2022;208(6):1178\u20139.","journal-title":"J Urol"},{"issue":"30","key":"6651_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.reth.2025.07.007","volume":"29","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhang X, Zhang H, Zhang S, Liu Z, Wu S, et al. A bibliometric analysis of the global status of platelet-rich plasma in regenerative medicine from 2004 to 2023. Regen Ther. 2025;29(30):456\u201364.","journal-title":"Regen Ther"},{"key":"6651_CR13","doi-asserted-by":"crossref","unstructured":"Mussano F, Genova T, Munaron L, Petrillo S, Erovigni F, Carossa. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. 2016;1\u20135.","DOI":"10.3109\/09537104.2016.1143922"},{"key":"6651_CR14","doi-asserted-by":"crossref","unstructured":"Altalbawy FMA, Mukhlif BAM, Hussen A, Mohammed JS, S RJ, Singh A, Mishra SB, Chauhan AS, Astaneh ME, Fereydouni N. Regenerative\u00a0potential of PRP-based scaffolds in chronic wound healing: mechanisms, advances, and therapeutic insights. Regen Ther. 2025;30:278\u2013298.","DOI":"10.1016\/j.reth.2025.06.008"},{"issue":"2","key":"6651_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12035-013-8494-7","volume":"48","author":"DP Kuffler","year":"2013","unstructured":"Kuffler DP. Platelet-rich plasma and the elimination of neuropathic pain. Mol Neurobiol. 2013;48(2):315\u201332.","journal-title":"Mol Neurobiol"},{"key":"6651_CR16","doi-asserted-by":"crossref","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC. Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis\/bladder pain syndrome. Tzu Chi Med J.\u00a02025;37(1):72\u20139.","DOI":"10.4103\/tcmj.tcmj_166_24"},{"key":"6651_CR17","doi-asserted-by":"crossref","unstructured":"Mourad MS, Tawfick A, Kotb M, Saleh IM, Salim MS, Samir YR. Efficacy and safety of submucosal intravesical injection of platelet-rich plasma in the treatment of interstitial cystitis\/painful bladder syndrome.\u00a0Int Urogynecol J. 2026;37(3):655\u201362.","DOI":"10.1007\/s00192-025-06324-6"},{"key":"6651_CR18","doi-asserted-by":"crossref","unstructured":"Taneja R, Pandey S, Priyadarshi S, Goel A, Jain A, Sharma R, Purohit N, Bandukwalla V, Tanvir, Ragavan M, Agrawal A, Shah A, Girn Z, Ajwani V, Mete U. Diagnostic and therapeutic cystoscopy in bladder pain syndrome\/interstitial cystitis: systematic review of literature and consensus on methodology. Int Urogynecol J. 2023;34(6):1165\u20131173.","DOI":"10.1007\/s00192-023-05449-w"},{"issue":"1","key":"6651_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","volume":"36","author":"WR Yu","year":"2024","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC. Cystoscopic characteristic findings of interstitial cystitis and clinical implications. Tzu Chi Med J. 2024;36(1):30\u20137.","journal-title":"Tzu Chi Med J"},{"key":"6651_CR20","doi-asserted-by":"crossref","unstructured":"Werneburg GT, Moldwin R, Lowell Parsons C, M SP, Sinha S, J QC. Interstitial cystitis\/Bladder Pain Syndrome (IC\/BPS) diagnosis: current limitations and a pragmatic clinical diagnostic definition.\u00a0Neurourol Urodyn. 2026;45(1):32\u20138.","DOI":"10.1002\/nau.70112"},{"issue":"6 Suppl 1","key":"6651_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0090-4295(01)01126-8","volume":"57","author":"DP Lubeck","year":"2001","unstructured":"Lubeck DP, Whitmore K, Sant GR, Alvarez-Horine S, Lai C. Psychometric validation of the O\u2019leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology. 2001;57(6 Suppl 1):62\u20136.","journal-title":"Urology"},{"issue":"6","key":"6651_CR22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/nau.23542","volume":"37","author":"YC Kuo","year":"2018","unstructured":"Kuo YC, Kuo HC. Videourodynamic characteristics of interstitial cystitis\/bladder pain syndrome-the role of bladder outlet dysfunction in the pathophysiology. Neurourol Urodyn. 2018;37(6):1971\u20137.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"6651_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/nau.23898","volume":"38","author":"JF Jhang","year":"2019","unstructured":"Jhang JF, Lin TY, Kuo HC. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-a prospective clinical trial. Neurourol Urodyn. 2019;38(2):703\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"6651_CR24","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/nau.24500","volume":"39","author":"C Ronstrom","year":"2020","unstructured":"Ronstrom C, Lai HH. Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy. Neurourol Urodyn. 2020;39(8):2394\u2013400.","journal-title":"Neurourol Urodyn"},{"issue":"30","key":"6651_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.reth.2025.09.007","volume":"15","author":"J Chen","year":"2025","unstructured":"Chen J, Liu B, He J, Wei Y, He Y, Zhou H, et al. Multimodal mechanisms of platelet-rich plasma in bone defect repair: Angiogenesis, inflammation modulation, and metabolic regulation. Regen Ther. 2025;15(30):920\u201332.","journal-title":"Regen Ther"},{"issue":"1","key":"6651_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72292-0","volume":"10","author":"YH Jiang","year":"2020","unstructured":"Jiang YH, Kuo YC, Jhang JF, Lee CL, Hsu YH, Ho HC, et al. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis. Sci Rep. 2020;10(1):15218.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"6651_CR27","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"JF Jhang","year":"2022","unstructured":"Jhang JF, Jiang YH, Hsu YH, Ho HC, Birder LA, Lin TY, et al. Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int Neurourol J. 2022;26(Suppl 1):S57-67.","journal-title":"Int Neurourol J"},{"issue":"5","key":"6651_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.23736\/S2724-6051.25.06232-9","volume":"77","author":"HR Li","year":"2025","unstructured":"Li HR, Wang T, Shen SH, Peng L. The efficacy and safety of intravesical platelet-rich plasma injections into the bladder for the treatment of interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis. Minerva Urol Nephrol. 2025;77(5):605\u201317.","journal-title":"Minerva Urol Nephrol"},{"issue":"1","key":"6651_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00345-025-05451-5","volume":"43","author":"WR Yu","year":"2025","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC. Focal or diffuse bladder wall thickness on bladder computed tomography indicates more severe bladder wall inflammation in patients with interstitial cystitis. World J Urol. 2025;43(1):100.","journal-title":"World J Urol"},{"key":"6651_CR30","doi-asserted-by":"crossref","unstructured":"Behzadi P, Kim CH, Pawlak EA, Algammal A. Editorial: The innate andadaptive immune system in human urinary system. Front Immunol. 2023;14:1294869.","DOI":"10.3389\/fimmu.2023.1294869"},{"issue":"Pt 2","key":"6651_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137836","volume":"284","author":"P Behzadi","year":"2025","unstructured":"Behzadi P, Chandran D, Chakraborty C, Bhattacharya M, Saikumar G, Dhama K, Chakraborty A, Mukherjee S, Sarshar M. The dual role oftoll-like receptors in COVID-19: Balancing protective immunity andimmunopathogenesis. Int J Biol Macromol. 2025;284(Pt 2): 137836.","journal-title":"Int J Biol Macromol."},{"key":"6651_CR32","doi-asserted-by":"crossref","unstructured":"Shie JH, Liu HT, Kuo HC. Increased cell apoptosis of urothelium mediated byinflammation in interstitial cystitis\/painful bladder syndrome. Urology. 2012;79(2):484.e7\u201313.","DOI":"10.1016\/j.urology.2011.09.049"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06651-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:36:30Z","timestamp":1791466590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6651"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06651-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board and Research Ethics Committee of Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, IRB code: 115-015-B, dated Feb. 05, 2026).","order":1,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}